Tasonermin
- TRADE NAME: Beromun (Boehringer Ingelheim)
- INDICATIONS: As an adjunct to surgery for subsequent removal of various tumors
- CLASS: Immune stimulant, TNF alpha agonist
- HALF-LIFE: 0.37 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Anthracyclines , Interferon Gamma, Melphalan
Please login to see the rest of this drug profile
SKIN.
NAILS.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric